Lyrica
Pricing Report NDC 0071-1019-68

Current NADAC: $9.68304 per EA · Effective Aug 19, 2026 · Est. package price $871.47 (90 EA)

Current Package Pricing Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

The current wholesale acquisition cost for Lyrica (NDC 0071-1019-68) is $9.68304 per EA. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Aug 19, 2026.

As a provided by Parke-davis Div Of Pfizer Inc, this medication is distributed in a 90 CAPSULE in 1 BOTTLE configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$9.68304
Per EA

Effective Date
Aug 19, 2026
Billable Units
90 EA
Estimated Package Price
$871.47
Data Status
As of Aug 19, 2026
C/I - Chain or Independent Pharmacy
Package NDC
Description
90 CAPSULE in 1 BOTTLE
Generic Benchmark
The generic equivalent rate is $0.05620 (Effective: Aug 19, 2026)
Pricing Methodology Explanation
The NADAC was calculated using information from the most recently completed pharmacy survey.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Jul 2013, the NADAC wholesale price for (NDC ) has moved within a range of $3.59395 to $9.73698 per EA. Over this 13 years and 1 month period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$3.5940 - $9.7370
Market Volatility
170.93% Variance
Latest Trend
0.05%

Recent NADAC Price History

DateUnit PriceUnitSourceMethodRate
Aug 19, 2026 $9.68304 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Jul 22, 2026 $9.67839 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Jun 17, 2026 $9.67301 EAC/I - Chain or Independent PharmacyCode 1B - Brand
May 20, 2026 $9.68284 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Apr 22, 2026 $9.67422 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Mar 18, 2026 $9.67745 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Feb 18, 2026 $9.68731 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Jan 21, 2026 $9.68435 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Dec 17, 2025 $9.70427 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Nov 19, 2025 $9.67755 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Oct 22, 2025 $9.68314 EAC/I - Chain or Independent PharmacyCode 1B - Brand
Sep 17, 2025 $9.68054 EAC/I - Chain or Independent PharmacyCode 1B - Brand

Earlier NADAC Price History

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 2: The average acquisition cost of the most recent survey was within ± 2% of the current NADAC; therefore, the NADAC was carried forward from the previous file.
  • Code 3: The NADAC based on survey data has been adjusted to reflect changes in published pricing, or as a result of an inquiry to the help desk.
  • Code 4: The NADAC was carried forward from the previous file.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.


Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: September 09, 2026